CoChat

Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype

Open access
Chow, Nienwen, Bell, Robert D., Deane, Rashid, Streb, Jeffrey W., Chen, Jiyuan, Brooks, Andrew, Van Nostrand, William, Miano, Joseph M., Zlokovic, Berislav V. · 2007 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

Cerebral angiopathy contributes to cognitive decline and dementia in Alzheimer's disease (AD) through cerebral blood flow (CBF) reductions and dysregulation. We report vascular smooth muscle cells (VSMC) in small pial and intracerebral arteries, which are critical for CBF regulation, express in AD high levels of serum response factor (SRF) and myocardin (MYOCD), two interacting transcription factors that orchestrate a VSMC-differentiated phenotype. Consistent with this finding, AD VSMC overexpressed several SRF-MYOCD-regulated contractile proteins and exhibited a hypercontractile phenotype. MYOCD overexpression in control human cerebral VSMC induced an AD-like hypercontractile phenotype and diminished both endothelial-dependent and -independent relaxation in the mouse aorta ex vivo . In contrast, silencing SRF normalized contractile protein content and reversed a hypercontractile phenotype in AD VSMC. MYOCD in vivo gene transfer to mouse pial arteries increased contractile protein content and diminished CBF responses produced by brain activation in wild-type mice and in two AD models, the Dutch/Iowa/Swedish triple mutant human amyloid β-peptide (Aβ)-precursor protein ( APP )- expressing mice and APPsw +/− mice. Silencing Srf had the opposite effect. Expression of SRF did not change in VSMC subjected to Alzheimer's neurotoxin, Aβ. Thus, SRF-MYOCD overexpression in small cerebral arteries appears to initiate independently of Aβ a pathogenic pathway mediating arterial hypercontractility and CBF dysregulation, which are associated with Alzheimer's dementia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0608251104

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Research works printed but not linked: 1

  1. 10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8 · doi:10.1002/1531-8249(200006)47:6<739::aid-ana6>3.0.co;2-8

Cited by

See all 209

Metadata

Authors
Chow, N., Bell, R. D., Deane, R., Streb, J. W., Chen, J., Brooks, A., Van Nostrand, W., Miano, J. M., & Zlokovic, B. V.
Affiliations
  • *Socratech Research Laboratories L.L.C.,
  • Frank P. Smith Laboratories for Neuroscience and Neurosurgical Research, Department of Neurosurgery,
  • Cardiovascular Institute Hospital (JP)
  • University of Rochester Medicine (US)
  • Department of Medicine, Stony Brook University, Stony Brook, NY 11794
Venue
Proceedings of the National Academy of Sciences
Published
2007-01-16
Volume
104
Issue
3
Pages
823-828
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2113727732
Cited by
209
References
53
Citations by year
2026: 3 · 2025: 3 · 2024: 7 · 2023: 9 · 2022: 13 · 2021: 12 · 2020: 5 · 2019: 6 · 2018: 7 · 2017: 9 · 2016: 9 · 2015: 14 · 2014: 13 · 2013: 14 · 2012: 13
FWCI
11.14
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (1r43ag024000-01)
  • National Institute on Aging (R41AG026950, R37AG023084, R43 AG024000, 1R43 AG 024000, 1R41 AG 026950 01)
  • National Heart, Lung, and Blood Institute (HL 62572, R01HL062572)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords
Alzheimer's disease, serum response factor, myocardin, vascular smooth muscle cells, cerebral blood flow, cerebral angiopathy, contractile proteins, pial arteries, APP transgenic mice, amyloid-beta, transcription factors, gene transfer, vascular dysfunction
MeSH terms
Myocardin, Alzheimer Disease, Animals, Cells, Cultured, Cerebral Arteries, Humans, Mice, Inbred C57BL, Nuclear Proteins, Phenotype, Potassium Chloride, Regional Blood Flow, Trans-Activators, Serum Response Factor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype. https://app.cochat.ai/papers/10.1073/pnas.0608251104
The paper
Chow, N., Bell, R. D., Deane, R., Streb, J. W., Chen, J., Brooks, A., Van Nostrand, W., Miano, J. M., & Zlokovic, B. V. (2007). Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0608251104

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.